Vizient Calls on Industry Stakeholders to Join Alliance to End Drug Shortages
Retrieved on:
Monday, November 8, 2021
Vizient, Inc. today announced the formation of a new alliance to end drug shortages in the U.S.
Key Points:
- Vizient, Inc. today announced the formation of a new alliance to end drug shortages in the U.S.
- The End Drug Shortages Alliance will provide a forum for key stakeholders across the industry to take strategic aim at one of the health care industrys most pressing and enduring issues.
- In 2019, a Vizient member survey revealed that managing drug shortages costs U.S. hospitals more than $359 million annually in labor alone.
- The End Drug Shortages Alliance will formally bring together industry stakeholders, including providers, group purchasing organizations, manufacturers, distributors and other industry thought leaders and champions.